Mira Pharmaceuticals (MIRA) Other Non-Current Assets (2023)

Mira Pharmaceuticals' (MIRA) quarterly Other Non-Current Assets came in at $3.5 million in Q4 2023, little changed quarter-over-quarter from $3.5 million in Q3 2023.

Mira Pharmaceuticals (MIRA) Other Non-Current Assets (2023) Analysis & Trends

Mira Pharmaceuticals has disclosed Other Non-Current Assets across 1 years of filings, most recently posting $3.5 million for Q4 2023.

  • Other Non-Current Assets for Q4 2023 came in at $3.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $3.5 million (changed N/A YoY), and the FY2023 annual result was $3.5 million, changed N/A from the prior year.
  • Other Non-Current Assets came in at $3.5 million for Q4 2023 at Mira Pharmaceuticals, roughly flat from $3.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.5 million in Q2 2023 to a low of $3.5 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 3.18 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 7.23 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 14.11 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 10.54 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 19.81 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 12.76 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 4.55 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 9.83 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 6.08 Bn
10 Mira Pharmaceuticals 23.69 Mn 12.66 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 3.50 Mn
Sep 30, 2023 3.50 Mn
Jun 30, 2023 3.50 Mn